Transition Therapeutics Inc.

Transition Therapeutics Inc. is a fully integrated biopharmaceutical company with a proprietary state-of-the art drug discovery engine and extensive drug development program exploring novel therapeutics in multiple disease indications. The focus of the corporate business is to discover and advance lead molecules to the most valuable and competitive targets in the industry using our state-of-the-art drug discovery engine, to accelerate the development of multiple products for large disease indications and to generate shareholder value through partnership with major pharmaceutical companies. ( www.transitiontherapeutics.com )